photo of Dr Svenja Pachernegg

Dr Svenja Pachernegg

Dr Svenja Pachernegg

Details

Role Senior Project Manager
Research area Stem Cell Medicine

Contact

Dr Svenja Pachernegg is a senior biomedical scientst and research program manager with 15+ years international experience driving complex research projects and securing competitive funding (AUD 2.6M). Proven leader of teams up to 20 personnel with expertise in strategic planning, project management, and full grant lifecycle support (pre- and post-award), including budgeting (AUD 1M+) and ethics compliance.
Dr Svenja Pachernegg is a senior biomedical scientst and research program manager with 15+ years international experience driving complex research projects and securing competitive funding (AUD 2.6M). Proven leader of teams up to 20 personnel with...
Dr Svenja Pachernegg is a senior biomedical scientst and research program manager with 15+ years international experience driving complex research projects and securing competitive funding (AUD 2.6M). Proven leader of teams up to 20 personnel with expertise in strategic planning, project management, and full grant lifecycle support (pre- and post-award), including budgeting (AUD 1M+) and ethics compliance.

Top Publications

  • Mao, M, Mattei, C, Rollo, B, Byars, S, Cuddy, C, Berecki, G, Heighway, J, Pachernegg, S, Menheniott, T, Apted, D, et al. Distinctive in vitro phenotypes in iPSC-derived neurons from patients with gain- and loss-of-function SCN2A developmental and epileptic encephalopathy. 2026
    view publication
  • Ferreira, LGA, Kizys, MML, Gama, GAC, Pachernegg, S, Robevska, G, Sinclair, AH, Ayers, KL, da Silva, MRD. COUP-TFII regulates early bipotential gonad signaling and commitment to ovarian progenitors. 2026
    view publication
  • Jia, L, Li, M, Pachernegg, S, Sedo, A, Jancovski, N, Burbano, LE, Dalby, K, Nemiroff, A, Reid, C, Maljevic, S, et al. Variant-specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy.. J Neurochem 168(12) : 3950 -3961 2024
    view publication
  • Pachernegg, S, Robevska, G, G A Ferreira, L, van den Bergen, JA, Vlahos, K, Howden, SE, Sinclair, AH, Ayers, KL. Generation of heterozygous (MCRIi031-A-1) and homozygous (MCRIi031-A-2) SOX9 knockout human iPSC lines.. Stem Cell Res 79: 103484 2024
    view publication
  • Pachernegg, S, Robevska, G, Ferreira, LGA, van den Bergen, JA, Vlahos, K, Howden, SE, Sinclair, AH, Ayers, KL. Generation of a homozygous (MCRIi031-A-3) WT1 knockout human iPSC line.. Stem Cell Res 79: 103494 2024
    view publication

Page 1 of 5

Career information